Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction

Completed · Phase 3

Conditions studied: Erectile Dysfunction

In brief

An open-label investigation using MED3000 gel or tadalafil (5 mg) tablets in the treatment of erectile dysfunction in patients from 22 to 70 years of age. Each patients will be expected to participate for up to 30 weeks. Eligible patients will be randomised to receive either MED3000 gel or tadalafil (5 mg) tablets in a 1:1 ratio.

Key facts

Study ID
NCT04984993
Run by
Futura Medical Developments Ltd.
People needed
116
Starts
2021-09-14
Expected to finish
2022-07-13
Last updated by the study team
2023-09-21

Who can join

Age: 22 and older, up to 70. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.